Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Chun-Yang Fan

Concepts (278)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
14
2010
281
1.760
Why?
Carcinoma, Squamous Cell
15
2010
326
1.660
Why?
DNA Methylation
13
2009
544
1.130
Why?
DNA Glycosylases
5
2011
19
1.060
Why?
Gene Silencing
7
2009
114
1.050
Why?
Promoter Regions, Genetic
11
2009
467
1.040
Why?
Mitochondria
3
2011
394
0.530
Why?
DNA Repair
5
2008
185
0.520
Why?
Adaptor Proteins, Signal Transducing
5
2009
197
0.480
Why?
Polymerase Chain Reaction
11
2009
453
0.480
Why?
Kidney Neoplasms
2
2008
172
0.470
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
153
0.470
Why?
DNA, Neoplasm
10
2008
145
0.460
Why?
Nuclear Proteins
5
2009
240
0.460
Why?
Neoplasm Proteins
4
2005
322
0.420
Why?
Laryngeal Neoplasms
3
2007
41
0.390
Why?
Vascular Endothelial Growth Factor A
2
2009
201
0.370
Why?
CpG Islands
3
2008
106
0.370
Why?
Lung Neoplasms
2
2007
600
0.350
Why?
Microsatellite Instability
1
2009
18
0.340
Why?
Fatty Liver
1
2011
127
0.340
Why?
Immunohistochemistry
7
2012
983
0.330
Why?
Mitochondrial Proteins
2
2007
88
0.330
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.320
Why?
Port-Wine Stain
1
2008
14
0.320
Why?
Oxygen
1
2011
324
0.310
Why?
O(6)-Methylguanine-DNA Methyltransferase
2
2005
9
0.300
Why?
Genes, p16
3
2005
9
0.300
Why?
Lymph Nodes
2
2007
261
0.290
Why?
DNA, Mitochondrial
4
2011
110
0.290
Why?
N-Glycosyl Hydrolases
1
2007
6
0.290
Why?
Carcinoma, Renal Cell
1
2008
101
0.290
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2007
15
0.290
Why?
Skin
3
2010
412
0.290
Why?
Aged
15
2011
9434
0.280
Why?
Adenoma
1
2008
111
0.280
Why?
Mitochondria, Liver
1
2007
69
0.280
Why?
Cisplatin
3
2007
275
0.270
Why?
Proteoglycans
2
2003
81
0.260
Why?
Fibroma
1
2006
39
0.260
Why?
Aged, 80 and over
8
2009
3132
0.250
Why?
Liver
1
2011
1110
0.250
Why?
Middle Aged
16
2011
12258
0.240
Why?
Membrane Glycoproteins
2
2003
247
0.240
Why?
Survival Analysis
5
2009
669
0.240
Why?
Carcinoma, Hepatocellular
1
2007
194
0.240
Why?
Humans
36
2013
49863
0.230
Why?
Prognosis
7
2007
1948
0.230
Why?
DNA Repair Enzymes
1
2004
42
0.230
Why?
Ataxia Telangiectasia
1
2004
6
0.230
Why?
Salivary Ducts
1
2003
3
0.230
Why?
Salivary Gland Neoplasms
1
2003
7
0.230
Why?
Adenocarcinoma, Clear Cell
1
2003
34
0.220
Why?
Receptors, Cytoplasmic and Nuclear
1
2003
64
0.220
Why?
Liver Neoplasms
1
2007
329
0.220
Why?
Obesity
1
2011
1101
0.210
Why?
Adult
14
2011
13325
0.200
Why?
Female
22
2012
26520
0.200
Why?
Nitric Oxide Synthase Type III
2
2013
78
0.200
Why?
Male
21
2012
25439
0.200
Why?
Epigenesis, Genetic
1
2004
369
0.180
Why?
Transcription Factors
1
2003
558
0.170
Why?
Antineoplastic Agents
2
2010
1173
0.170
Why?
Skin Transplantation
2
2010
43
0.170
Why?
Carrier Proteins
4
2005
302
0.160
Why?
Skin Neoplasms
4
2008
489
0.160
Why?
Tumor Suppressor Proteins
2
2011
128
0.150
Why?
Loss of Heterozygosity
2
2008
77
0.150
Why?
DNA Damage
2
2011
297
0.140
Why?
Survival Rate
3
2009
904
0.140
Why?
Neoplasm Invasiveness
4
2007
268
0.130
Why?
Graft Survival
3
2011
151
0.120
Why?
Ki-67 Antigen
2
2011
57
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
594
0.120
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
2005
33
0.120
Why?
Algorithms
2
2008
613
0.120
Why?
Immunoenzyme Techniques
4
2013
144
0.120
Why?
Cadherins
2
2005
64
0.120
Why?
Prostatic Neoplasms
2
2008
390
0.110
Why?
Thyroid Neoplasms
2
2007
111
0.110
Why?
Keratosis
2
2003
13
0.110
Why?
Receptors, Cell Surface
1
2013
123
0.100
Why?
Base Sequence
2
2004
644
0.100
Why?
Carcinoma in Situ
2
2003
73
0.100
Why?
Lymphangioma, Cystic
1
2011
10
0.100
Why?
Laryngectomy
3
2007
27
0.100
Why?
Arteriovenous Malformations
1
2013
68
0.100
Why?
Leukoplakia, Oral
1
2011
6
0.100
Why?
Aminolevulinic Acid
1
2011
8
0.100
Why?
Endothelium, Lymphatic
1
2011
12
0.100
Why?
Lasers, Dye
1
2011
9
0.100
Why?
Wound Healing
2
2010
204
0.100
Why?
Antigens, CD
1
2013
218
0.100
Why?
Cell Line, Tumor
4
2010
1387
0.100
Why?
Photosensitizing Agents
1
2011
19
0.100
Why?
Propranolol
1
2012
78
0.100
Why?
Lymphatic Abnormalities
1
2011
22
0.100
Why?
Microtubule-Associated Proteins
1
2011
65
0.100
Why?
Photochemotherapy
1
2011
33
0.100
Why?
Biopsy
3
2011
591
0.090
Why?
Homeodomain Proteins
1
2011
79
0.090
Why?
Laser Therapy
1
2011
84
0.090
Why?
Taxoids
1
2010
37
0.090
Why?
Drug Resistance, Multiple
1
2010
24
0.090
Why?
Hemangioma
1
2012
83
0.090
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2010
55
0.090
Why?
Follow-Up Studies
4
2011
2174
0.090
Why?
Gene Deletion
1
2011
267
0.090
Why?
Neoplasm Staging
3
2007
748
0.090
Why?
Gene Expression Regulation, Neoplastic
4
2010
822
0.080
Why?
Mice, Transgenic
1
2011
541
0.080
Why?
Disease Models, Animal
2
2011
1448
0.080
Why?
Animals
8
2011
13133
0.080
Why?
Paraffin Embedding
1
2008
52
0.080
Why?
Sulfites
1
2008
1
0.080
Why?
Drug Resistance, Neoplasm
1
2010
313
0.080
Why?
Microsatellite Repeats
1
2008
37
0.080
Why?
Blood Glucose
1
2011
433
0.080
Why?
Mice
4
2011
5671
0.080
Why?
Neoplasm Seeding
1
2008
4
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
993
0.080
Why?
Chordoma
1
2008
8
0.080
Why?
Skull Base Neoplasms
1
2008
20
0.080
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.080
Why?
Laryngeal Nerves
1
2007
15
0.070
Why?
Receptors, Thyrotropin
1
2007
7
0.070
Why?
Apoptosis Regulatory Proteins
2
2005
85
0.070
Why?
Symporters
1
2007
17
0.070
Why?
Methylation
2
2007
118
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2005
61
0.070
Why?
Pattern Recognition, Automated
1
2007
41
0.070
Why?
Image Enhancement
1
2007
54
0.070
Why?
Risk Factors
3
2008
3597
0.070
Why?
Cell Proliferation
1
2011
999
0.070
Why?
Precancerous Conditions
1
2008
83
0.070
Why?
Prostate
1
2008
117
0.070
Why?
Carcinoma, Papillary
1
2007
49
0.070
Why?
Transgenes
1
2007
52
0.070
Why?
Child, Preschool
3
2012
3872
0.070
Why?
Child
5
2012
6838
0.070
Why?
Image Interpretation, Computer-Assisted
1
2007
105
0.070
Why?
Neoplasm Recurrence, Local
2
2008
627
0.070
Why?
MicroRNAs
1
2010
349
0.070
Why?
Cell Nucleus
1
2007
187
0.070
Why?
Syndecans
2
2003
34
0.070
Why?
RNA, Messenger
2
2007
1101
0.070
Why?
Protein Transport
1
2007
183
0.070
Why?
Artificial Intelligence
1
2007
82
0.070
Why?
Syndecan-1
2
2003
72
0.070
Why?
Genomics
1
2008
284
0.070
Why?
Adenomatous Polyposis Coli Protein
1
2005
2
0.060
Why?
Receptors, Atrial Natriuretic Factor
1
2005
8
0.060
Why?
Atrial Natriuretic Factor
1
2005
25
0.060
Why?
Ear, Inner
1
2005
17
0.060
Why?
Melanoma
1
2008
282
0.060
Why?
Guanine
1
2004
40
0.060
Why?
Cell Physiological Phenomena
1
2004
3
0.060
Why?
Cell Cycle Proteins
1
2005
163
0.060
Why?
Cytochromes c
1
2003
30
0.060
Why?
DNA Adducts
1
2004
79
0.060
Why?
Salivary Proteins and Peptides
1
2003
8
0.060
Why?
Statistics as Topic
1
2003
87
0.060
Why?
Isoenzymes
1
2003
169
0.050
Why?
Base Pair Mismatch
1
2003
22
0.050
Why?
Adenocarcinoma, Follicular
1
2003
4
0.050
Why?
Adenocarcinoma, Papillary
1
2003
5
0.050
Why?
Tunica Intima
1
2003
55
0.050
Why?
Adenoma, Oxyphilic
1
2003
11
0.050
Why?
Cell Count
1
2003
147
0.050
Why?
Retrospective Studies
4
2007
6106
0.050
Why?
DNA-Binding Proteins
1
2005
418
0.050
Why?
Keratoacanthoma
1
2002
7
0.050
Why?
Collagen
1
2003
209
0.050
Why?
Renal Dialysis
1
2003
170
0.050
Why?
Platelet Aggregation Inhibitors
1
2003
174
0.050
Why?
Alcohol Drinking
1
2003
226
0.050
Why?
Combined Modality Therapy
4
2004
638
0.050
Why?
Molecular Sequence Data
1
2003
791
0.050
Why?
Lung
1
2005
499
0.050
Why?
Cohort Studies
1
2005
1400
0.050
Why?
Blotting, Western
2
2013
600
0.050
Why?
Adolescent
2
2012
6392
0.050
Why?
Blood Platelets
1
2003
248
0.050
Why?
Prevalence
1
2004
951
0.050
Why?
Tomography, X-Ray Computed
1
2006
1152
0.050
Why?
Smoking
1
2003
505
0.040
Why?
Random Allocation
2
2010
285
0.040
Why?
Quality of Life
1
2004
837
0.040
Why?
Electrophoresis, Agar Gel
2
2008
11
0.040
Why?
Sensitivity and Specificity
2
2010
855
0.030
Why?
Hyperplasia
2
2008
96
0.030
Why?
Neck Dissection
2
2008
30
0.030
Why?
Dose-Response Relationship, Drug
2
2011
1354
0.030
Why?
Fluorouracil
2
2004
55
0.030
Why?
Photosensitivity Disorders
2
2003
10
0.030
Why?
Cross-Sectional Studies
2
2012
1568
0.030
Why?
Infant
2
2012
3565
0.030
Why?
Lymph Node Excision
2
2004
137
0.030
Why?
Head
1
2013
70
0.030
Why?
Actins
1
2013
115
0.030
Why?
Neck
1
2013
99
0.030
Why?
Treatment Outcome
3
2011
5165
0.030
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Antigens, Nuclear
1
2011
24
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
47
0.020
Why?
Administration, Topical
1
2011
56
0.020
Why?
Tissue Culture Techniques
1
2011
37
0.020
Why?
Transplantation, Heterologous
1
2011
75
0.020
Why?
Time Factors
2
2010
2889
0.020
Why?
Mice, Nude
1
2011
252
0.020
Why?
Neoplasms, Squamous Cell
1
2010
7
0.020
Why?
Rats
2
2009
3293
0.020
Why?
Pharmacogenetics
1
2010
51
0.020
Why?
Granulation Tissue
1
2010
9
0.020
Why?
Tissue and Organ Harvesting
1
2010
23
0.020
Why?
Myeloid Cells
1
2010
37
0.020
Why?
Probability
1
2010
162
0.020
Why?
Endothelial Cells
1
2011
260
0.020
Why?
Carcinoma
1
2010
139
0.020
Why?
Graft Rejection
1
2010
168
0.020
Why?
Pilot Projects
1
2011
700
0.020
Why?
Neovascularization, Physiologic
1
2009
68
0.020
Why?
Thymine
1
2008
10
0.020
Why?
Chi-Square Distribution
1
2009
275
0.020
Why?
Centromere
1
2008
11
0.020
Why?
Microdissection
1
2008
19
0.020
Why?
Cell Line, Transformed
1
2008
73
0.020
Why?
Telomere
1
2008
36
0.020
Why?
Melanocytes
1
2008
38
0.020
Why?
Gene Dosage
1
2008
78
0.020
Why?
Fluorescent Dyes
1
2008
105
0.020
Why?
Iodine
1
2007
10
0.020
Why?
Genetic Markers
1
2008
102
0.020
Why?
Mice, Knockout
1
2010
842
0.020
Why?
Predictive Value of Tests
1
2010
907
0.020
Why?
Fatal Outcome
1
2008
194
0.020
Why?
Cluster Analysis
1
2007
232
0.020
Why?
Epithelial Cells
1
2008
209
0.020
Why?
Prospective Studies
1
2011
2341
0.020
Why?
Buffers
1
2005
9
0.020
Why?
Round Window, Ear
1
2005
6
0.020
Why?
Injections
1
2005
56
0.020
Why?
Rats, Inbred Lew
1
2005
69
0.020
Why?
Phosphates
1
2005
46
0.020
Why?
Rats, Sprague-Dawley
1
2009
1574
0.020
Why?
Sodium Chloride
1
2005
56
0.020
Why?
Protein Isoforms
1
2005
118
0.020
Why?
Drug Combinations
1
2005
126
0.020
Why?
Mice, Inbred C57BL
1
2010
1795
0.020
Why?
Antibodies
1
2005
152
0.020
Why?
Statistics, Nonparametric
1
2004
193
0.010
Why?
Reproducibility of Results
1
2007
1180
0.010
Why?
Disease-Free Survival
1
2005
452
0.010
Why?
Platelet Adhesiveness
1
2003
13
0.010
Why?
Elastin
1
2003
23
0.010
Why?
Polytetrafluoroethylene
1
2003
32
0.010
Why?
DNA Primers
1
2003
207
0.010
Why?
Up-Regulation
1
2005
448
0.010
Why?
Radiotherapy
1
2004
124
0.010
Why?
Anastomosis, Surgical
1
2003
66
0.010
Why?
Dogs
1
2003
185
0.010
Why?
Vascular Patency
1
2003
83
0.010
Why?
Radiotherapy, Adjuvant
1
2003
60
0.010
Why?
Myocytes, Smooth Muscle
1
2003
86
0.010
Why?
Chemotherapy, Adjuvant
1
2003
121
0.010
Why?
Extracellular Matrix
1
2003
108
0.010
Why?
Graft Occlusion, Vascular
1
2003
74
0.010
Why?
Thyroidectomy
1
2003
59
0.010
Why?
Biopsy, Needle
1
2003
181
0.010
Why?
Young Adult
1
2012
4013
0.010
Why?
Lymphatic Metastasis
1
2003
226
0.010
Why?
Stromal Cells
1
2002
72
0.010
Why?
Models, Biological
1
2003
722
0.010
Why?
Risk Assessment
1
2003
1253
0.010
Why?
Arkansas
1
2004
1982
0.010
Why?
Diagnosis, Differential
1
2002
1038
0.010
Why?
Pregnancy
1
2003
2469
0.010
Why?
Fan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description